Literature DB >> 20375174

Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus.

Joseph G Victoria1, Chunlin Wang, Morris S Jones, Crystal Jaing, Kevin McLoughlin, Shea Gardner, Eric L Delwart.   

Abstract

Metagenomics and a panmicrobial microarray were used to examine eight live-attenuated viral vaccines. Viral nucleic acids in trivalent oral poliovirus (OPV), rubella, measles, yellow fever, varicella-zoster, multivalent measles/mumps/rubella, and two rotavirus live vaccines were partially purified, randomly amplified, and pyrosequenced. Over half a million sequence reads were generated covering from 20 to 99% of the attenuated viral genomes at depths reaching up to 8,000 reads per nucleotides. Mutations and minority variants, relative to vaccine strains, not known to affect attenuation were detected in OPV, mumps virus, and varicella-zoster virus. The anticipated detection of endogenous retroviral sequences from the producer avian and primate cells was confirmed. Avian leukosis virus (ALV), previously shown to be noninfectious for humans, was present as RNA in viral particles, while simian retrovirus (SRV) was present as genetically defective DNA. Rotarix, an orally administered rotavirus vaccine, contained porcine circovirus-1 (PCV1), a highly prevalent nonpathogenic pig virus, which has not been shown to be infectious in humans. Hybridization of vaccine nucleic acids to a panmicrobial microarray confirmed the presence of endogenous retroviral and PCV1 nucleic acids. Deep sequencing and microarrays can therefore detect attenuated virus sequence changes, minority variants, and adventitious viruses and help maintain the current safety record of live-attenuated viral vaccines.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20375174      PMCID: PMC2876658          DOI: 10.1128/JVI.02690-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  A virus discovery method incorporating DNase treatment and its application to the identification of two bovine parvovirus species.

Authors:  T Allander; S U Emerson; R E Engle; R H Purcell; J Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

2.  Evidence of infection with simian type D retrovirus in persons occupationally exposed to nonhuman primates.

Authors:  N W Lerche; W M Switzer; J L Yee; V Shanmugam; A N Rosenthal; L E Chapman; T M Folks; W Heneine
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  No evidence of infectious retroviruses in measles virus vaccines produced in chicken embryo cell cultures.

Authors:  M Shahabuddin; J F Sears; A S Khan
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

4.  Characterization of endogenous avian leukosis viruses in chicken embryonic fibroblast substrates used in production of measles and mumps vaccines.

Authors:  J A Johnson; W Heneine
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Absence of evidence for porcine circovirus type 2 in cattle and humans, and lack of seroconversion or lesions in experimentally infected sheep.

Authors:  G M Allan; F McNeilly; I McNair; M D Curran; I Walker; J Ellis; C Konoby; S Kennedy; B Meehan
Journal:  Arch Virol       Date:  2000       Impact factor: 2.574

6.  Porcine circovirus type 2 in muscle and bone marrow is infectious and transmissible to naïve pigs by oral consumption.

Authors:  Tanja Opriessnig; Abby R Patterson; Xiang-Jin Meng; Patrick G Halbur
Journal:  Vet Microbiol       Date:  2008-07-04       Impact factor: 3.293

7.  Metagenomic analyses of viruses in stool samples from children with acute flaccid paralysis.

Authors:  Joseph G Victoria; Amit Kapoor; Linlin Li; Olga Blinkova; Beth Slikas; Chunlin Wang; Asif Naeem; Sohail Zaidi; Eric Delwart
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

8.  Lack of evidence of endogenous avian leukosis virus and endogenous avian retrovirus transmission to measles, mumps, and rubella vaccine recipients.

Authors:  A I Hussain; V Shanmugam; W M Switzer; S X Tsang; A Fadly; D Thea; R Helfand; W J Bellini; T M Folks; W Heneine
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

9.  Complete DNA sequences of two oka strain varicella-zoster virus genomes.

Authors:  Sueli L Tillieux; Wendy S Halsey; Elizabeth S Thomas; John J Voycik; Ganesh M Sathe; Ventzislav Vassilev
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

10.  Comparative analysis of the complete nucleotide sequences of measles, mumps, and rubella strain genomes contained in Priorix-Tetra and ProQuad live attenuated combined vaccines.

Authors:  Sueli L Tillieux; Wendy S Halsey; Ganesh M Sathe; Ventzislav Vassilev
Journal:  Vaccine       Date:  2009-01-31       Impact factor: 3.641

View more
  104 in total

1.  Massively parallel sequencing for monitoring genetic consistency and quality control of live viral vaccines.

Authors:  Alexander Neverov; Konstantin Chumakov
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

2.  Host RNAs, including transposons, are encapsidated by a eukaryotic single-stranded RNA virus.

Authors:  Andrew Routh; Tatiana Domitrovic; John E Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-24       Impact factor: 11.205

Review 3.  From orphan virus to pathogen: the path to the clinical lab.

Authors:  Linlin Li; Eric Delwart
Journal:  Curr Opin Virol       Date:  2011-10       Impact factor: 7.090

4.  The perils of pathogen discovery: origin of a novel parvovirus-like hybrid genome traced to nucleic acid extraction spin columns.

Authors:  Samia N Naccache; Alexander L Greninger; Deanna Lee; Lark L Coffey; Tung Phan; Annie Rein-Weston; Andrew Aronsohn; John Hackett; Eric L Delwart; Charles Y Chiu
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

Review 5.  Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines.

Authors:  Olufemi Samuel Folorunso; Olihile M Sebolai
Journal:  Vaccines (Basel)       Date:  2020-06-27

6.  Risk Assessment for Use of a Porcine Circovirus-Contaminated Reagent in a Barrier Maintained Rodent Colony.

Authors:  Norman C Peterson; Aaron A Berlin
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-06-30       Impact factor: 1.232

7.  The serological evidence in humans supports a negligible risk of zoonotic infection from porcine circovirus type 2.

Authors:  Peter D Burbelo; Jack A Ragheb; Amit Kapoor; Yanjin Zhang
Journal:  Biologicals       Date:  2013-10-10       Impact factor: 1.856

8.  Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions.

Authors:  Therese Högfeldt; Crystal Jaing; Kevin Mc Loughlin; James Thissen; Shea Gardner; Abeer A Bahnassy; Baback Gharizadeh; Joachim Lundahl; Anders Österborg; Anna Porwit; Abdel-Rahman N Zekri; Hussein M Khaled; Håkan Mellstedt; Ali Moshfegh
Journal:  Oncol Lett       Date:  2016-08-16       Impact factor: 2.967

Review 9.  Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years.

Authors:  Edwin J Asturias; Melinda Wharton; Robert Pless; Noni E MacDonald; Robert T Chen; Nicholas Andrews; David Salisbury; Alexander N Dodoo; Kenneth Hartigan-Go; Patrick L F Zuber
Journal:  Vaccine       Date:  2016-05-16       Impact factor: 3.641

10.  Treatment and prevention of rotavirus infection in children.

Authors:  Penelope H Dennehy
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.